Clarametyx Biosciences Secures $33M in Series A Funding to Propel Anti-Biofilm Technology
Key Highlights Clarametyx Biosciences Inc. secures $33 million in Series A funding, targeting persistent infections associated with biofilms. Funds…
Browsing Tag
C Bio Investors
1 post